We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 81-100 of 437 results
  1. Health and Racial Disparity in Breast Cancer

    Breast cancer is the most common noncutaneous malignancy and the second most lethal form of cancer among women in the United States. It currently...
    Clement G. Yedjou, Jennifer N. Sims, ... Paul B. Tchounwou in Breast Cancer Metastasis and Drug Resistance
    Chapter 2019
  2. Current and Future Perspectives of Combining Chemotherapy and Stereotactic Body Radiation Therapy with Immunotherapy in the Treatment of Lung Cancer

    Lung cancer is a huge public health concern all over the world, including India, and for many years, the gold standard treatment has been the...
    Abhishek Krishna, Elroy Saldanha, ... Manjeshwar Shrinath Baliga in Immunotherapy Against Lung Cancer
    Chapter 2024
  3. Radiation therapy with phenotypic medicine: towards N-of-1 personalization

    In current clinical practice, radiotherapy (RT) is prescribed as a pre-determined total dose divided over daily doses (fractions) given over several...

    Li Ming Chong, Peter Wang, ... Dean Ho in British Journal of Cancer
    Article 21 March 2024
  4. Prospective results of concurrent radiation therapy and weekly paclitaxel as salvage therapy for unresectable locoregionally recurrent breast cancer

    Purpose

    To investigate the efficacy and toxicity of concurrent radiation therapy (RT) and paclitaxel in the treatment of unresectable locoregionally...

    Gang Cai, Lu Cao, ... Jia-Yi Chen in Radiation Oncology
    Article Open access 02 July 2019
  5. Comparative survival analysis of multiparametric tests—when molecular tests disagree—A TEAM Pathology study

    Multiparametric assays for risk stratification are widely used in the management of both node negative and node positive hormone receptor positive...

    John M. S. Bartlett, Jane Bayani, ... Daniel Rea in npj Breast Cancer
    Article Open access 08 July 2021
  6. Clinical Application of Immunotherapy in the Perioperative Management of Head and Neck Cancer

    Immunotherapy has changed the landscape of recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) and is now an essential element...
    Frederick M. Howard, Nishant Agrawal, Ari J. Rosenberg in Immunotherapy for Head and Neck Cancer
    Chapter 2022
  7. Immune recurrence score using 7 immunoregulatory protein expressions can predict recurrence in stage I–III breast cancer patients

    Background

    Immune cells in the tumour microenvironment play an essential role in tumorigenesis. This study aimed to evaluate the immunoregulatory...

    Dae-Won Lee, Han Suk Ryu, ... Seock-Ah Im in British Journal of Cancer
    Article Open access 11 July 2019
  8. HVEM in acute lymphocytic leukemia facilitates tumour immune escape by inhibiting CD8+ T cell function

    Purpose

    Leukaemia remains a major contributor to global mortality, representing a significant health risk for a substantial number of cancer patients....

    Yujia Liu, Lixiang Wang, ... Wei Yi in Cellular Oncology
    Article 29 May 2024
  9. Artificial neural network models to predict nodal status in clinically node-negative breast cancer

    Background

    Sentinel lymph node biopsy (SLNB) is standard staging procedure for nodal status in breast cancer, but lacks therapeutic benefit for...

    Looket Dihge, Mattias Ohlsson, ... Lisa Rydén in BMC Cancer
    Article Open access 21 June 2019
  10. Diffusion, MRI, and Cancer Diagnosis: Physicist’s Outlook

    A very elegant application of nuclear magnetic resonance (NMR) phenomenon is imaging the 1HNMR signals emitted from water molecules of human cells...
    Susanta Kumar Sen Gupta in Cancer Diagnostics and Therapeutics
    Chapter 2022
  11. The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: a large study from a single institution

    Background

    Previous studies have reported up to 50% of ductal carcinoma in situ (DCIS), is HER2 positive, but the frequency of HER2-positive invasive...

    Islam M. Miligy, Michael S. Toss, ... Emad A. Rakha in British Journal of Cancer
    Article Open access 08 May 2019
  12. Radiation-induced lung toxicity – cellular and molecular mechanisms of pathogenesis, management, and literature review

    Lung, breast, and esophageal cancer represent three common malignancies with high incidence and mortality worldwide. The management of these tumors...

    Lukas Käsmann, Alexander Dietrich, ... Claus Belka in Radiation Oncology
    Article Open access 10 September 2020
  13. Prognostic models for breast cancer: a systematic review

    Background

    Breast cancer is the most common cancer in women worldwide, with a great diversity in outcomes among individual patients. The ability to...

    Minh Tung Phung, Sandar Tin Tin, J. Mark Elwood in BMC Cancer
    Article Open access 14 March 2019
  14. Predictive and prognostic value of ZEB1 protein expression in breast cancer patients with neoadjuvant chemotherapy

    Background

    Zinc finger E-box binding homeobox 1 (ZEB1) is a molecule involved in the progression of epithelial-to-mesenchymal transition (EMT) in...

    Zi** Wu, Lei Zhang, ... **song Lu in Cancer Cell International
    Article Open access 29 March 2019
  15. Neonatal Fc Receptor–Targeted Therapies in Neurology

    Autoantibodies are increasingly recognized for their pathogenic potential in a growing number of neurological diseases. While myasthenia gravis...

    Christopher Nelke, Marianna Spatola, ... Jan D. Lünemann in Neurotherapeutics
    Article Open access 07 January 2022
  16. Single dose of dexamethasone is not associated with postoperative recurrence and mortality in breast cancer patients: a propensity-matched cohort study

    Background

    Dexamethasone is widely used in cancer patients despite the concern that perioperative glucocorticoids may potentially cause...

    Myoung Hwa Kim, Dong Wook Kim, ... Young Chul Yoo in BMC Cancer
    Article Open access 20 March 2019
  17. The effect of neoadjuvant platinum-based chemotherapy in BRCA mutated triple negative breast cancers -systematic review and meta-analysis

    Background

    Triple negative breast cancers (TNBC) are associated with an aggressive clinical course, earlier recurrence and short survival. BRCA –...

    Olga Caramelo, Cristina Silva, ... Teresa Almeida-Santos in Hereditary Cancer in Clinical Practice
    Article Open access 25 March 2019
  18. Preliminary toxicity results using partial breast 3D-CRT with once daily hypo-fractionation and deep inspiratory breath hold

    Background

    To evaluate the clinical outcomes of patients treated with 3D conformal H ypo-fractionated, deep I nspiratory breath-hold (DIBH), P artial...

    Roman O. Kowalchuk, Kara D. Romano, ... Monica M. Morris in Radiation Oncology
    Article Open access 27 July 2018
  19. Clonal relatedness in tumour pairs of breast cancer patients

    Background

    Molecular classification of tumour clonality is currently not evaluated in multiple invasive breast carcinomas, despite evidence suggesting...

    Jana Biermann, Toshima Z. Parris, ... Khalil Helou in Breast Cancer Research
    Article Open access 09 August 2018
  20. Stem-like exhausted and memory CD8+ T cells in cancer

    T cells can acquire a broad spectrum of differentiation states following activation. At the extreme ends of this continuum are short-lived cells...

    Thomas Gebhardt, Simone L. Park, Ian A. Parish in Nature Reviews Cancer
    Article 11 October 2023
Did you find what you were looking for? Share feedback.